Investeringsoversigt

8477 investments

Titel Sort descending	Periode	Program
Development of 2nd gen. LastSwap reusable personal hygiene swab to reduce single use plastic waste	2021 - 2022	Innobooster
Development of 2nd gen. LastSwap reusable personal hygiene swab to reduce single use plastic waste Period 2021 - 2022 Region Region Hovedstaden Program Innobooster Area Ikke defineret Investment Percentage 33 Invested 499.445 Budget 1.5 mill. Partners LastObject ApS People LastObject ApS Read more about the project
Development of a cholesterol-lowering virus-like particle based vaccine targeting PCSK9	2018 - 2021	Industrial Researcher
Development of a cholesterol-lowering virus-like particle based vaccine targeting PCSK9 Period 2018 - 2021 Region Region Hovedstaden Program Erhvervsforsker Area Biotek, Medico og Sundhed Investment Percentage 37.59 Invested 1.1 mill. Budget 2.9 mill. Partners University of Copenhagen, AdaptVac ApS People AdaptVac ApS Read more about the project
Development of a computational protocol for using Nanodiscs as lipid bilayer mimics during drug discovery	2018 - 2021	Industrial Researcher
Development of a computational protocol for using Nanodiscs as lipid bilayer mimics during drug discovery Period 2018 - 2021 Region Region Hovedstaden Program Erhvervsforsker Area Biotek, Medico og Sundhed Investment Percentage 76.85 Invested 1.1 mill. Budget 1.4 mill. Partners Aarhus University, Novo Nordisk A/S People Novo Nordisk A/S Read more about the project
Development of a deep learning-assisted platform for confident and complete characterization of host cell proteins in complex biopharmaceuticals	2023 - 2026	Industrial Researcher
Development of a deep learning-assisted platform for confident and complete characterization of host cell proteins in complex biopharmaceuticals Period 2023 - 2026 Region Program Erhvervsforsker Area Ikke defineret Investment Percentage 60.16 Invested 1.1 mill. Budget 1.8 mill. The meticulous monitoring of host cell proteins (HCP) is of paramount importance for biopharmaceutical development and safety. This project aims to develop a novel deep learning-driven platform that facilitates in-depth HCP characterization of complex biopharmaceuticals via mass spectrometry (MS) data. This involves development of, an automated MS quality control pipeline, a deep learning-based protein identification workflow, and a curation method to augment proteome databases. Partners University of Southern Denmark, ALPHALYSE A/S People Read more about the project
Development of a first-of-a-kind complete solution for DNA methylation analysis	2019 - 2019	Innobooster
Development of a first-of-a-kind complete solution for DNA methylation analysis Period 2019 - 2019 Region Region Nordjylland Program Innobooster Area Biotek, Medico og Sundhed Investment Percentage 33 Invested 443.932 Budget 1.3 mill. Partners MethylDetect ApS People Methyl Detect ApS Read more about the project
Development of a long-acting dual GIP/GLP-2 tool compound for chronic PoC studies.	2019 - 2022	Industrial Researcher
Development of a long-acting dual GIP/GLP-2 tool compound for chronic PoC studies. Period 2019 - 2022 Region Region Hovedstaden Program Erhvervsforsker Area Biotek, Medico og Sundhed Investment Percentage 54.14 Invested 1.1 mill. Budget 2.0 mill. Partners University of Copenhagen, Bainan Biotech ApS People Bainan Biotech ApS Read more about the project
DEVELOPMENT OF A MEDIUM SCALE TEST SET-UP FOR THE FIRE PERFORMANCE ASSESSMENT OF FAÇADE SYSTEMS	2016 - 2017	Industrial Researcher
DEVELOPMENT OF A MEDIUM SCALE TEST SET-UP FOR THE FIRE PERFORMANCE ASSESSMENT OF FAÇADE SYSTEMS Period 2016 - 2017 Region Region Hovedstaden Program Erhvervsforsker Area Ikke defineret Investment Percentage 42.96 Invested 403.841 Budget 940.000 Partners Dansk Brand- og sikringsteknisk Institut People Dansk Brand- og sikringsteknisk Institut Read more about the project
Development of a Methodology for the Definition of Battery Fire Scenarios	2024 - 2027	Industrial Researcher
Development of a Methodology for the Definition of Battery Fire Scenarios Period 2024 - 2027 Region Program Erhvervsforsker Area Ikke defineret Investment Percentage 36.92 Invested 1.2 mill. Budget 3.2 mill. .Afhængighed af grønne løsninger nødvendiggør energilagring, hvilket gør batterier til en vigtig del af den grønne omstilling. Øget brug af batterier i vores samfund har skiftet fokus til batteri brandsikkerhed. På trods af at teknologien er bredt accepteret og anvendt, mangler der ingeniørmetoder til batteri brandsikkerhedsdesign, hvilket kan blive skadeligt for teknologiimplementeringen. Dette projekt vil undersøge brandudviklingen i batterier og udvikle metoder til batteri-designbrande. Partners Dansk Brand- og sikringsteknisk Institut People Read more about the project
Development of a new type of highly potent and safe toxoid-based vaccine against bacterial infections	2022 - 2023	Innobooster
Development of a new type of highly potent and safe toxoid-based vaccine against bacterial infections Period 2022 - 2023 Region Program Innobooster Area Ikke defineret Investment Percentage 34 Invested 999.600 Budget 2.9 mill. Partners Proxi Biotech ApS People Read more about the project
Development of a novel low-volume in vitro pig (LovInPig) gut model with increased throughput	2018 - 2021	Industrial Researcher
Development of a novel low-volume in vitro pig (LovInPig) gut model with increased throughput Period 2018 - 2021 Region Region Hovedstaden Program Erhvervsforsker Area Biotek, Medico og Sundhed Investment Percentage 65.13 Invested 1.3 mill. Budget 2.0 mill. Partners University of Copenhagen, Chr. Hansen A/S People Chr. Hansen A/S Read more about the project
Development of a novel multi-targeted T-cell therapy product against HPV-induced cervical cancer	2023 - 2026	Industrial Researcher
Development of a novel multi-targeted T-cell therapy product against HPV-induced cervical cancer Period 2023 - 2026 Region Program Erhvervsforsker Area Ikke defineret Investment Percentage 59.1 Invested 1.1 mill. Budget 1.8 mill. Vha. en banebrydende teknologi udviklet af prof. Sine Hadrup på DTU kan man i laboratoriet selektivt ekspandere de immunceller (T-celler), som, når de kommer tilbage i patienten, vil opspore og udrydde kræften. Sammen med Cbio A/S, der fokuserer på denne nye klasse af ’levende drugs’ er målet at udvikle en kurativ behandling imod senstadie livmoderhalskræft, som er klar til klinisk udvikling og derved bringe et nyt produkt på markedet i slut 2020erne til gavn for kvinder med denne kræftform. Partners Technical University of Denmark, CBio A/S People Read more about the project
Development of a novel platform for in vivo evaluation of blood brain barrier penetration of CNS-targeting drugs	2021 - 2024	Industrial Researcher
Development of a novel platform for in vivo evaluation of blood brain barrier penetration of CNS-targeting drugs Period 2021 - 2024 Region Region Hovedstaden Program Erhvervsforsker Area Ikke defineret Investment Percentage 30.03 Invested 1.1 mill. Budget 3.6 mill. Partners University of Copenhagen, MINERVA IMAGING ApS People MINERVA IMAGING ApS Read more about the project
Development of a Novel Platform for Screening Interactions with Human Serum Albumin	2017 - 2020	Industrial Researcher
Development of a Novel Platform for Screening Interactions with Human Serum Albumin Period 2017 - 2020 Region Region Hovedstaden Program Erhvervsforsker Area Biotek, Medico og Sundhed Investment Percentage 41.71 Invested 1.1 mill. Budget 2.6 mill. Partners Aarhus University, Novo Nordisk A/S People Novo Nordisk A/S Read more about the project
Development of a novel point-of-care device to measure inflammation (suPAR) in fingerprick blood	2021 - 2023	Innobooster
Development of a novel point-of-care device to measure inflammation (suPAR) in fingerprick blood Period 2021 - 2023 Region Region Hovedstaden Program Innobooster Area Ikke defineret Investment Percentage 33 Invested 2.8 mill. Budget 8.6 mill. Partners ViroGates A/S People VIROGATES A/S Read more about the project
Development of a peptide-based CD133-targeting optical probe for image-guided cancer surgery	2020 - 2023	Industrial Researcher
Development of a peptide-based CD133-targeting optical probe for image-guided cancer surgery Period 2020 - 2023 Region Region Hovedstaden Program Erhvervsforsker Area Biotek, Medico og Sundhed Investment Percentage 100 Invested 1.2 mill. Budget 1.2 mill. Partners University of Copenhagen, FluoGuide A/S People FluoGuide A/S Read more about the project